MECHANISMS OF FORMATION OF HEART DYSFUNCTION AND THE APPLICATION OF SAKUBUTRI/VALSARTAN IN DIABETES MELLITUS

Ташкенбаева Наргиза Фархадовна, Тригулова Раиса Хусаиновна, Халикова Азиза Ойбековна, Мухтарова Шахноза Шокиржоновна

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali · 2021-yil

Annotatsiya

The incidence of diabetes mellitus (DM) in patients with heart failure (HF) is about 40%, regardless of the level of ejection fraction (EF) impairment. But, in addition, diabetes is considered a strong independent risk factor for the progression of heart failure with both preserved and reduced EF and is usually associated with a poor prognosis. The ability of neprilisin inhibitors to increase levels of biologically active natriuretic peptides has made them a potential therapeutic approach in the treatment of HF. The use of sacubitril/valsartan in patients with heart failure with diabetes continues to be studied.

Maqola ma’lumotlari
MualliflarТашкенбаева Наргиза Фархадовна, Тригулова Раиса Хусаиновна, Халикова Азиза Ойбековна, Мухтарова Шахноза Шокиржоновна
JurnalJournal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali
Nashr sanasi2021-08-06
Jild2
Son2
TilRus

Kalit so‘zlar

сердечная недостаточность, сахарный диабет, фракция выброса, сакубитрил/валсартан, heart failure, diabetes mellitus, ejection fraction, sacubitril/valsartan, yurak yetishmovchiligi, qandli diabet, yurakning otish fraktsiyasi, sakubitril/valsartan

Ilmiy soha

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali jurnalidan boshqa maqolalar

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar